U.S. pharma large copyright scrapped two experimental weight loss pills final calendar year—a as soon as-day-to-day tablet, lotiglipron, on account of elevated liver enzymes plus a two times-day-to-day tablet, danuglipron, because of powerful Negative effects—but CEO Albert Bourla ha